Inhibition of infectivity of human immunodeficiency virus by oxetanocin. 1987

H Hoshino, and N Shimizu, and N Shimada, and T Takita, and T Takeuchi

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

H Hoshino, and N Shimizu, and N Shimada, and T Takita, and T Takeuchi
May 1989, Antimicrobial agents and chemotherapy,
H Hoshino, and N Shimizu, and N Shimada, and T Takita, and T Takeuchi
April 1990, AIDS research and human retroviruses,
H Hoshino, and N Shimizu, and N Shimada, and T Takita, and T Takeuchi
March 1996, Antiviral research,
H Hoshino, and N Shimizu, and N Shimada, and T Takita, and T Takeuchi
November 2002, Journal of virology,
H Hoshino, and N Shimizu, and N Shimada, and T Takita, and T Takeuchi
December 1990, The Journal of general virology,
H Hoshino, and N Shimizu, and N Shimada, and T Takita, and T Takeuchi
June 1989, Proceedings of the National Academy of Sciences of the United States of America,
H Hoshino, and N Shimizu, and N Shimada, and T Takita, and T Takeuchi
April 1991, Biochemical and biophysical research communications,
H Hoshino, and N Shimizu, and N Shimada, and T Takita, and T Takeuchi
October 1995, Nature,
H Hoshino, and N Shimizu, and N Shimada, and T Takita, and T Takeuchi
December 2014, The Journal of general virology,
H Hoshino, and N Shimizu, and N Shimada, and T Takita, and T Takeuchi
January 1988, Japanese journal of cancer research : Gann,
Copied contents to your clipboard!